查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1862177

臨床試驗用品供應：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Clinical Trial Supplies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球臨床試驗用品市場規模估計為 23.64 億美元，預計到 2031 年將達到 40.99 億美元，在預測期（2025-2031 年）內複合年成長率為 8.3%。

臨床試驗供應是指為製藥公司、生技公司和受託研究機構(CRO) 在整個臨床試驗生命週期中提供臨床實驗藥物、對照藥物、試劑、醫療設備和輔助材料的綜合供應系統。核心服務包括臨床實驗藥物的生產、重新包裝、貼標、批次追蹤和儲存，以及臨床檢體採集試劑盒、伴隨診斷試劑和檢測專用設備的採購和交付。隨著創新藥物數量的不斷增加、多中心國際臨床試驗的日益複雜化以及個人化醫療的進步，臨床試驗供應已成為藥物研發的關鍵要素。透過整合數位化供應鏈管理、低溫運輸物流和合規營運，我們提供端到端、高品質、可追溯的供應解決方案，加速藥物的臨床檢驗和商業化進程，體現了我們在生命科學產業的創新能力和全球競爭力。

臨床試驗供應產業的成長動力源自於全球創新藥物和先進治療方法研發管線的快速擴張，以及多中心、國際性試驗日益複雜的趨勢。細胞和基因療法、RNA藥物以及精準醫療的日益普及，催生了對高度客製化、靈活且符合監管要求的供應解決方案的強勁需求。製藥公司正加大對策略夥伴關係和數位化供應鏈專案的投入，以提高試驗效率和監管合規性。同時，政府對醫藥創新的支持以及不斷完善的法規結構也推動了產業發展，使臨床試驗供應成為生命科學創新的基石。

由於複雜的全球監管要求和不斷上漲的營運成本，該行業面臨許多挑戰。各國在藥品生產品質管理規範/藥品生產品質管理規範 (GMP/GDP) 標準、藥品分銷政策和海關程序方面的差異，使跨境供應鏈更加複雜。對低溫運輸運輸、批次追溯和合規性審核日益成長的需求，要求持續投資於基礎設施、技術和人力資源開發。市場競爭、供應鏈中斷、地緣政治緊張局勢和公共衛生危機進一步加劇了全球業務營運的風險。

隨著臨床試驗模式從集中式轉向分散式、數位化和以患者為中心的模式轉變，對試驗耗材的需求也變得更加多樣化和複雜。製藥公司和合約研究組織（CRO）需要提高供應鏈的透明度、風險管理能力和資源分配的精準性。伴隨診斷、基因組檢測和罕見疾病研究的興起，推動了對高度客製化小批量耗材解決方案的需求。此外，遠端醫療和直接面向患者（DTP）的試驗模式正在擴大服務的覆蓋範圍和靈活性，並為臨床試驗物流的創新創造了機會。

上游環節包括臨床實驗原料藥、品管、試驗試劑、專用包裝及低溫運輸運輸系統。製藥企業、原料供應商和醫療設備製造商的技術創新正在推動供應鏈服務品質的整體提升。智慧包裝解決方案、高性能保溫設備和先進的溫度監控設備正日益成為標準配備。此外，數位化供應鏈平台和自動化倉儲系統的應用正在提高營運效率和標準化程度，增強臨床試驗用品的全球分銷能力。

本報告旨在按地區/國家、類型和應用對全球臨床試驗用品市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，對臨床試驗用品市場規模、估算和預測進行了呈現，基準年為2024年，並涵蓋了2020年至2031年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就臨床試驗用品做出明智的商業決策。

市場區隔

公司

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

按類型分類的細分市場

  • 物流/配送
  • 生產/包裝
  • 供應鏈管理
  • 其他

應用領域

  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Clinical Trial Supplies was estimated to be worth US$ 2364 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

Clinical Trial Supplies refer to the comprehensive supply system of investigational products, comparators, reagents, medical equipment, and ancillary materials required throughout the entire lifecycle of clinical trials for pharmaceutical companies, biotechnology firms, and contract research organizations (CROs). Core services include the manufacturing, repackaging, labeling, batch tracking, and storage of investigational drugs, as well as the sourcing and delivery of clinical sample collection kits, companion diagnostics, and trial-specific devices. As the number of innovative drugs grows, multi-center international clinical trials become more complex, and personalized medicine advances, clinical trial supplies have become an indispensable component of pharmaceutical R&D. By integrating digital supply chain management, cold-chain logistics, and compliance-driven operations, the sector provides end-to-end, high-quality, traceable supply solutions that accelerate clinical validation and commercialization of drugs, reflecting both innovation capacity and global competitiveness in the life sciences industry.

The clinical trial supplies industry is driven by the rapid growth of global pipelines for innovative drugs and advanced therapies, as well as the rising complexity of multi-center international trials. The expanding adoption of cell and gene therapies, RNA-based drugs, and precision medicine has created a strong demand for highly customized, flexible, and compliance-oriented supply solutions. Pharmaceutical companies are increasingly investing in strategic partnerships and digital supply chain initiatives to enhance trial efficiency and regulatory adherence. In parallel, government support for drug innovation and evolving regulatory frameworks are fostering industry growth, positioning clinical trial supplies as a cornerstone of life sciences innovation.

The sector faces challenges stemming from complex global regulatory requirements and rising operational costs. Differences in GMP/GDP standards, drug distribution policies, and customs clearance procedures across countries complicate cross-border supply chains. The growing need for cold-chain transportation, batch traceability, and compliance audits necessitates ongoing investment in infrastructure, technology, and workforce training. Market competition, supply chain disruptions, geopolitical tensions, and public health crises further increase risks for global operations.

As clinical trials shift from centralized to decentralized, digital, and patient-centric models, demand for trial supplies is becoming more diversified and sophisticated. Pharmaceutical companies and CROs require greater supply chain visibility, risk management, and precise resource allocation. The rise of companion diagnostics, genomic testing, and rare disease research has fueled the demand for highly customized, small-batch supply solutions. Additionally, telemedicine and direct-to-patient (DTP) trial models are expanding service reach and flexibility, unlocking new opportunities for innovation in clinical trial logistics.

The upstream segment comprises investigational drug substances, comparator products, laboratory reagents, specialized packaging, and cold-chain transportation systems. Technological advancements by pharmaceutical manufacturers, raw material suppliers, and medical device firms have enhanced the overall quality of supply services. Smart packaging solutions, high-performance insulation equipment, and advanced temperature monitoring devices are increasingly standard. Furthermore, the adoption of digital supply chain platforms and automated warehousing is improving operational efficiency and standardization, strengthening global distribution capabilities for clinical trial supplies.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supplies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supplies by region & country, by Type, and by Application.

The Clinical Trial Supplies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supplies.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

Segment by Type

  • Logistics & Distribution
  • Manufacturing and Packaging
  • Supply Chain Management
  • Other

Segment by Application

  • Phase I
  • Phase II
  • Phase III
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supplies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supplies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supplies in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Supplies Product Introduction
  • 1.2 Global Clinical Trial Supplies Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Supplies Market Trends & Drivers
    • 1.3.1 Clinical Trial Supplies Industry Trends
    • 1.3.2 Clinical Trial Supplies Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Supplies Market Challenges
    • 1.3.4 Clinical Trial Supplies Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Supplies Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Supplies Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Supplies Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Supplies Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supplies
  • 2.6 Clinical Trial Supplies Market Competitive Analysis
    • 2.6.1 Clinical Trial Supplies Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supplies Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supplies as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Logistics & Distribution
    • 3.1.2 Manufacturing and Packaging
    • 3.1.3 Supply Chain Management
    • 3.1.4 Other
  • 3.2 Global Clinical Trial Supplies Sales Value by Type
    • 3.2.1 Global Clinical Trial Supplies Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Supplies Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Supplies Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Phase I
    • 4.1.2 Phase II
    • 4.1.3 Phase III
    • 4.1.4 Other
  • 4.2 Global Clinical Trial Supplies Sales Value by Application
    • 4.2.1 Global Clinical Trial Supplies Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Supplies Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Supplies Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Supplies Sales Value by Region
    • 5.1.1 Global Clinical Trial Supplies Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Supplies Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Supplies Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Supplies Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Supplies Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Supplies Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Supplies Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Supplies Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Supplies Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Supplies Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Supplies Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Supplies Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Supplies Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Supplies Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Supplies Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Supplies Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Supplies Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Supplies Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Profile
    • 7.1.2 Thermo Fisher Scientific Main Business
    • 7.1.3 Thermo Fisher Scientific Clinical Trial Supplies Products, Services and Solutions
    • 7.1.4 Thermo Fisher Scientific Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Scientific Recent Developments
  • 7.2 Catalent Pharma Solutions
    • 7.2.1 Catalent Pharma Solutions Profile
    • 7.2.2 Catalent Pharma Solutions Main Business
    • 7.2.3 Catalent Pharma Solutions Clinical Trial Supplies Products, Services and Solutions
    • 7.2.4 Catalent Pharma Solutions Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Catalent Pharma Solutions Recent Developments
  • 7.3 Almac Group
    • 7.3.1 Almac Group Profile
    • 7.3.2 Almac Group Main Business
    • 7.3.3 Almac Group Clinical Trial Supplies Products, Services and Solutions
    • 7.3.4 Almac Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Almac Group Recent Developments
  • 7.4 Parexel International
    • 7.4.1 Parexel International Profile
    • 7.4.2 Parexel International Main Business
    • 7.4.3 Parexel International Clinical Trial Supplies Products, Services and Solutions
    • 7.4.4 Parexel International Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Parexel International Recent Developments
  • 7.5 UDG Healthcare
    • 7.5.1 UDG Healthcare Profile
    • 7.5.2 UDG Healthcare Main Business
    • 7.5.3 UDG Healthcare Clinical Trial Supplies Products, Services and Solutions
    • 7.5.4 UDG Healthcare Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.5.5 UDG Healthcare Recent Developments
  • 7.6 PCI Services
    • 7.6.1 PCI Services Profile
    • 7.6.2 PCI Services Main Business
    • 7.6.3 PCI Services Clinical Trial Supplies Products, Services and Solutions
    • 7.6.4 PCI Services Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.6.5 PCI Services Recent Developments
  • 7.7 Marken
    • 7.7.1 Marken Profile
    • 7.7.2 Marken Main Business
    • 7.7.3 Marken Clinical Trial Supplies Products, Services and Solutions
    • 7.7.4 Marken Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Marken Recent Developments
  • 7.8 Klifo A/S.
    • 7.8.1 Klifo A/S. Profile
    • 7.8.2 Klifo A/S. Main Business
    • 7.8.3 Klifo A/S. Clinical Trial Supplies Products, Services and Solutions
    • 7.8.4 Klifo A/S. Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Klifo A/S. Recent Developments
  • 7.9 Walden Group
    • 7.9.1 Walden Group Profile
    • 7.9.2 Walden Group Main Business
    • 7.9.3 Walden Group Clinical Trial Supplies Products, Services and Solutions
    • 7.9.4 Walden Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Walden Group Recent Developments
  • 7.10 Bilcare Limited
    • 7.10.1 Bilcare Limited Profile
    • 7.10.2 Bilcare Limited Main Business
    • 7.10.3 Bilcare Limited Clinical Trial Supplies Products, Services and Solutions
    • 7.10.4 Bilcare Limited Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Bilcare Limited Recent Developments
  • 7.11 Biocair
    • 7.11.1 Biocair Profile
    • 7.11.2 Biocair Main Business
    • 7.11.3 Biocair Clinical Trial Supplies Products, Services and Solutions
    • 7.11.4 Biocair Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Supplies Industrial Chain
  • 8.2 Clinical Trial Supplies Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Supplies Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Supplies Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Supplies Market Trends
  • Table 2. Clinical Trial Supplies Market Drivers & Opportunity
  • Table 3. Clinical Trial Supplies Market Challenges
  • Table 4. Clinical Trial Supplies Market Restraints
  • Table 5. Global Clinical Trial Supplies Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Supplies Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Supplies Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Supplies Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Supplies
  • Table 10. Global Clinical Trial Supplies Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supplies as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Supplies Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Supplies Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Supplies Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Supplies Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Supplies Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Supplies Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Supplies Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Supplies Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Supplies Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Supplies Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Supplies Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Supplies Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Supplies Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Supplies Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Supplies Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Supplies Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Supplies Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Supplies Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Scientific Basic Information List
  • Table 32. Thermo Fisher Scientific Description and Business Overview
  • Table 33. Thermo Fisher Scientific Clinical Trial Supplies Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Supplies Business of Thermo Fisher Scientific (2020-2025)
  • Table 35. Thermo Fisher Scientific Recent Developments
  • Table 36. Catalent Pharma Solutions Basic Information List
  • Table 37. Catalent Pharma Solutions Description and Business Overview
  • Table 38. Catalent Pharma Solutions Clinical Trial Supplies Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Supplies Business of Catalent Pharma Solutions (2020-2025)
  • Table 40. Catalent Pharma Solutions Recent Developments
  • Table 41. Almac Group Basic Information List
  • Table 42. Almac Group Description and Business Overview
  • Table 43. Almac Group Clinical Trial Supplies Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Supplies Business of Almac Group (2020-2025)
  • Table 45. Almac Group Recent Developments
  • Table 46. Parexel International Basic Information List
  • Table 47. Parexel International Description and Business Overview
  • Table 48. Parexel International Clinical Trial Supplies Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Supplies Business of Parexel International (2020-2025)
  • Table 50. Parexel International Recent Developments
  • Table 51. UDG Healthcare Basic Information List
  • Table 52. UDG Healthcare Description and Business Overview
  • Table 53. UDG Healthcare Clinical Trial Supplies Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Supplies Business of UDG Healthcare (2020-2025)
  • Table 55. UDG Healthcare Recent Developments
  • Table 56. PCI Services Basic Information List
  • Table 57. PCI Services Description and Business Overview
  • Table 58. PCI Services Clinical Trial Supplies Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Supplies Business of PCI Services (2020-2025)
  • Table 60. PCI Services Recent Developments
  • Table 61. Marken Basic Information List
  • Table 62. Marken Description and Business Overview
  • Table 63. Marken Clinical Trial Supplies Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Supplies Business of Marken (2020-2025)
  • Table 65. Marken Recent Developments
  • Table 66. Klifo A/S. Basic Information List
  • Table 67. Klifo A/S. Description and Business Overview
  • Table 68. Klifo A/S. Clinical Trial Supplies Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Supplies Business of Klifo A/S. (2020-2025)
  • Table 70. Klifo A/S. Recent Developments
  • Table 71. Walden Group Basic Information List
  • Table 72. Walden Group Description and Business Overview
  • Table 73. Walden Group Clinical Trial Supplies Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Supplies Business of Walden Group (2020-2025)
  • Table 75. Walden Group Recent Developments
  • Table 76. Bilcare Limited Basic Information List
  • Table 77. Bilcare Limited Description and Business Overview
  • Table 78. Bilcare Limited Clinical Trial Supplies Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Supplies Business of Bilcare Limited (2020-2025)
  • Table 80. Bilcare Limited Recent Developments
  • Table 81. Biocair Basic Information List
  • Table 82. Biocair Description and Business Overview
  • Table 83. Biocair Clinical Trial Supplies Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Supplies Business of Biocair (2020-2025)
  • Table 85. Biocair Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Clinical Trial Supplies Downstream Customers
  • Table 89. Clinical Trial Supplies Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Supplies Product Picture
  • Figure 2. Global Clinical Trial Supplies Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Supplies Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Supplies Report Years Considered
  • Figure 5. Global Clinical Trial Supplies Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Supplies Revenue in 2024
  • Figure 7. Clinical Trial Supplies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Logistics & Distribution Picture
  • Figure 9. Manufacturing and Packaging Picture
  • Figure 10. Supply Chain Management Picture
  • Figure 11. Other Picture
  • Figure 12. Global Clinical Trial Supplies Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Clinical Trial Supplies Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Phase I
  • Figure 15. Product Picture of Phase II
  • Figure 16. Product Picture of Phase III
  • Figure 17. Product Picture of Other
  • Figure 18. Global Clinical Trial Supplies Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Clinical Trial Supplies Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Clinical Trial Supplies Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Clinical Trial Supplies Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Clinical Trial Supplies Sales Value (%), (2020-2031)
  • Figure 31. United States Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Clinical Trial Supplies Industrial Chain
  • Figure 53. Clinical Trial Supplies Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed